
Alison J. Moskowitz, MD
Lymphoma Specialist
Clinical Expertise
Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Cutaneous T Cell Lymphoma
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Moskowitz accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-608-3726 Office Phone
- Speaks English

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Albert Einstein College of Medicine
Residencies
Internal Medicine - Columbia University Medical Center
Fellowships
Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
Board Certifications
Medical Oncology; Hematology
I am a hematologist-oncologist who cares for people with lymphoma, including non-Hodgkin lymphoma. I have a particular focus on Hodgkin lymphoma, systemic T cell lymphoma, and cutaneous T cell lymphoma (a rare type of skin lymphoma).
Read more
I have been at Memorial Sloan Kettering for more than 11 years. I am part of a team of lymphoma experts who are committed not only to providing world-class care but also to finding newer and better ways to treat these diseases.
Hodgkin lymphoma is a relatively rare disease, but because of treatment advances, we can often cure it. By incorporating newer drugs into our current standard treatments, we can study how patients tolerate their treatment for Hodgkin lymphoma and can lessen the drugs’ long-term negative effects on the body.
T cell lymphoma is rare and can be challenging to treat. Our clinical trials in T cell lymphoma are testing targeted therapies and immunotherapies aimed at improving our ability to control the disease and patients’ quality of life — as well as the chance of a cure.
When I see patients for the first time, my goal is that they leave the appointment with a clear understanding of their diagnosis and treatment options, as well as the many resources available at MSK to help them cope with their treatment. I am fortunate to work with a team of nurses, social workers, and clinical assistants who create a comforting and supportive environment for our patients. While I understand that it is very scary for people to be told they have cancer, it is important to me that I help make the experience less scary and work with my patients so they feel as well as possible.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Moskowitz
- A Phase I Study of Nivolumab Immunotherapy plus Standard Chemotherapy for Newly Diagnosed High-Risk Hodgkin Lymphoma
- A Phase I Study of Ruxolitinib and Duvelisib to Treat Recurrent or Persistent T-Cell or NK-Cell Lymphomas
- A Phase I Study of SEA-TGT Immunotherapy in People with Classical Hodgkin Lymphoma
- A Phase II Study Assessing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Read more
- A Phase II Study of Brentuximab Vedotin with Chemotherapy and Immunotherapy in People with Classical Hodgkin Lymphoma
- A Phase II Study of Entinostat plus Pembrolizumab Immunotherapy for Recurrent or Persistent Hodgkin Lymphoma
- A Phase II Study of Pembrolizumab Immunotherapy plus Chemotherapy followed by Autologous Stem Cell Transplantation for Recurrent or Persistent Hodgkin Lymphoma
- A Phase II Study of Pembrolizumab Immunotherapy plus Gemcitabine to Treat Advanced Mycosis Fungoides or Sézary Syndrome
- A Phase II Study of Pembrolizumab Immunotherapy plus Involved Site Radiation Therapy to Treat Early Recurrent or Persistent Hodgkin Lymphoma
- A Phase II Study of Ruxolitinib in Patients with Persistent or Recurrent T-Cell or NK-Cell Lymphoma
- A Phase II Study to Determine the Optimal Dose of Brentuximab Vedotin for Mycosis Fungoides and Lymphomatoid Papulosis
- A Pilot Study of Pembrolizumab Immunotherapy in Patients with Extranodal NK/T-cell Nasal-Type Lymphoma
- Clinical Trials Co-Investigated by Dr. Moskowitz
- A Phase I Study Assessing the Addition of Lenalidomide to the Usual Combination Chemotherapy for HTLV-Associated Adult T-Cell Leukemia-Lymphoma
- A Phase I Study of N-Acetylcysteine in People Receiving CAR T-Cell Therapy for Lymphoma
- A Phase IB/II Study of Hu5F9-G4 (Magrolimab) in Combination with Mogamulizumab to Treat Recurrent or Persistent T-Cell Lymphoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Moskowitz’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Alison J. Moskowitz discloses the following relationships and financial interests:
-
Academic Medical Education
Provision of Services -
Affimed
Provision of Services -
BP - A Beneficencia Portuguesa de Sao Paulo
Provision of Services -
Canadian Hematology Society
Provision of Services -
Great Debates & Updates
Provision of Services -
Imbrium Therapeutics L.P.
Provision of Services -
International Symposium on Hodgkin Lymphoma
Provision of Services -
Janpix Limited
Provision of Services
-
Merck Sharp & Dohme
Provision of Services -
Physicians' Education Resource
Provision of Services -
Puerto Rico's Hematology and Medical Oncology Association (AHOMPR)
Provision of Services -
Seattle Genetics
Provision of Services -
Takeda Pharmaceuticals
Provision of Services -
Triangle Insights Group, LLC
Provision of Services -
UptoDate
Provision of Services -
WebMD
Provision of Services
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].